Trial Profile
Cervical Dystonia Patient Registry for the Observation of Botulinum Toxin Type A Efficacy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms CD PROBE; CD-PROBE
- Sponsors AbbVie; Allergan
- 27 Apr 2023 Results(n=114) assessing Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis and Retrocollis presented at the 75th Annual Meeting of the American Academy of Neurology 2023
- 18 Sep 2022 Results (n=55) assessing real-world treatment outcomes from retrocollis subtype of cervical dystonia presented at the 26th International Congress of Parkinson's Disease and Movement Disorders
- 25 Jul 2022 According to a AbbVie media release, data from the study will be presented at the TOXINS 2022 Conference to be held in New Orleans.